
FDA Approves Extended Release Deutetrabenazine for Tardive Dyskinesia, Chorea Associated With Huntington Disease
Austedo XR will be available in 3 extended-release tablet strengths, which provides an updated regimen that may result in a lower pill count for patients.















































